covid 19 News and Research

RSS

Cobra and AstraZeneca sign supply agreement for manufacture of COVID-19 vaccine candidate

Cobra Biologics, part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals, today announced it has signed a supply agreement with AstraZeneca UK Ltd. to provide GMP manufacture of the adenovirus vector-based COVID-19 vaccine candidate AZD1222, previously known as ChAdOx1 n-CoV-19.

From AstraZeneca 17 Jun 2020

C-OPN accelerates Parkinson’s disease research and treatment

Parkinson Canada invites people living with Parkinson’s disease to join the Canadian Open Parkinson Network to be part of the solution to improve lives for those living with Parkinson’s and ultimately to help discover a cure.

17 Jun 2020

Celltrion announces plans to launch COVID-19 point-of-care antigen testing kit

Celltrion Group today announced plans to expand its diagnostic portfolio for SARS-CoV-2, the virus causing COVID-19, in its efforts to improve access to COVID-19 testing and help prevent the further spread of coronavirus infection worldwide.

17 Jun 2020

BIA Separations launches novel PrimaS ligand technology to facilitate development of advanced therapies

BIA Separations, a leading bio-chromatography development and manufacturing company, today announced the introduction of its novel PrimaS ligand technology.

17 Jun 2020

CSIRO study reveals negative impact of COVID-19 on weight and emotional wellbeing

A new study by Australia’s national science agency, CSIRO, has found that weight and emotional wellbeing has suffered throughout the COVID-19 lockdown, with Australians also feeling concerned about how long it will take for life to return to “normal”.

17 Jun 2020

Free webinar series aims to improve care of pregnant women during COVID-19 pandemic

Health professionals around the globe can join a series of online expert workshops aimed at improving the care of pregnant women during the current COVID-19 pandemic, particularly in low- and middle-countries.

17 Jun 2020

Canadian coalition prepares to share research that could help against COVID-19

A Canadian group of companies is sharing their results with the scientific community in the hopes of accelerating the development of tests for COVID-19.

From SignalChem Biotech Inc. 17 Jun 2020

Specialist medical recruiter offers free open access to COVID Tracker and Digital Staff Bank for all NHS trusts

ID Medical is giving open access to its award-winning Digital Staff Bank and new COVID Tracker technology to all NHS trusts in the UK until October 2020.

17 Jun 2020

Medwise.ai wins Innovate UK funding to develop AI-powered platform that answers COVID-19 questions

Accelerate Cambridge and DigitalHealth.London launchpad company Medwise.ai announces it was selected from over 8600 applications to receive funding by the UK Government to develop an AI-powered platform that answers COVID-19 questions for healthcare professionals.

17 Jun 2020

Researchers take actions to reduce hospitalizations and deaths from COVID-19

Infectious disease experts from Fred Hutchinson Cancer Research Center and UW Medicine are advocating for earlier actions to reduce hospitalizations and deaths from COVID-19.

17 Jun 2020

An improved tetravalent antibody blocks SARS-CoV-2 infection

A new study published on the preprint server bioRxiv* in June 2020 shows the potential of a new fusion molecule called a biparatopic protein to inhibit viral interaction with the host cell ACE2 receptor. This could lead to therapeutic applications.

17 Jun 2020

BioRescue consortium is developing new technologies to prevent the extinction of species

In order to prevent the extinction of species such as the northern white rhino, the BioRescue consortium is developing new methods and technologies for conservation.

17 Jun 2020

Mapping RNA sequences of therapeutic value in the SARS-CoV-2 genome

Now, in new research published on the preprint server bioRxiv European scientists have performed RNA structure probing to obtain a single-base resolution secondary structure map of the full SARS-CoV-2 coronavirus genome.

17 Jun 2020

SARS-CoV-2 mutated spike proteins show variations in cell entry

A new study by Japanese scientists published on the preprint server bioRxiv* in June 2020 shows that the D614g mutation in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein can enhance the infectivity of the virus while leaving it vulnerable to neutralization by antibodies.

17 Jun 2020

Novel ACE2-antibody fusion molecules show anti-SARS-CoV-2 activity

Now, in a new study published on the preprint server, bioRxiv researchers in the U.S. investigated a soluble version of ACE2 for SARS-CoV-2 viral neutralization activity.

17 Jun 2020

Beijing lockdown due to new SARS-CoV-2 cluster, New Zealand records first case in weeks

China had started to return to normalcy after successfully "flattening the curve," with the government slowly easing restrictions and opening up the economy. However, Beijing has reported new clusters of coronavirus disease (COVID-19) cases, prompting the implementation of lockdown measures.

17 Jun 2020

Scientists isolate powerful SARS-CoV-2 -neutralizing antibodies from COVID-19 patients

A new study has shown that potent antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could help protect against COVID-19 infection. Preliminary results in animal studies have so far proven successful. The study titled, "Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model," was published in the latest issue of the journal Science.

17 Jun 2020

CSIRO study on the effects of COVID-19 on weight and well being

The CSIRO, Australia's federal government agency responsible for scientific research, has come up with a study looking at the emotional well being and weight loss or gain associated with the COVID-19 pandemic and the forced stay-at-home measures.

16 Jun 2020

Antibiotic X-206 effective against SARS-CoV-2 in vitro

The current study published on the preprint server bioRxiv aims to understand how these compounds affect SARS-CoV-2 in vitro. The researchers from Aarhus University in Denmark examined 11 natural PEIs, with a single synthetic analog, screening them for inhibitory activity against the CPE of SARS-CoV-2 infecting cultured cells with overexpression of TMPRSS2, a serine protease that is instrumental in cleaving the spike protein of the virus.

16 Jun 2020

Hepatitis C virus co-opts an immune protein to evade antiviral defenses

By discovering a trick the hepatitis C virus uses to evade the immune system, scientists have identified a new antiviral defense system that could be used to treat many virus infections, according to new research published today in eLife.

16 Jun 2020

covid 19 News and Research

Cobra and AstraZeneca sign supply agreement for manufacture of COVID-19 vaccine candidate

C-OPN accelerates Parkinson’s disease research and treatment

Celltrion announces plans to launch COVID-19 point-of-care antigen testing kit

BIA Separations launches novel PrimaS ligand technology to facilitate development of advanced therapies

CSIRO study reveals negative impact of COVID-19 on weight and emotional wellbeing

Free webinar series aims to improve care of pregnant women during COVID-19 pandemic

Canadian coalition prepares to share research that could help against COVID-19

Specialist medical recruiter offers free open access to COVID Tracker and Digital Staff Bank for all NHS trusts

Medwise.ai wins Innovate UK funding to develop AI-powered platform that answers COVID-19 questions

Researchers take actions to reduce hospitalizations and deaths from COVID-19

An improved tetravalent antibody blocks SARS-CoV-2 infection

BioRescue consortium is developing new technologies to prevent the extinction of species

Mapping RNA sequences of therapeutic value in the SARS-CoV-2 genome

SARS-CoV-2 mutated spike proteins show variations in cell entry

Novel ACE2-antibody fusion molecules show anti-SARS-CoV-2 activity

Beijing lockdown due to new SARS-CoV-2 cluster, New Zealand records first case in weeks

Scientists isolate powerful SARS-CoV-2 -neutralizing antibodies from COVID-19 patients

CSIRO study on the effects of COVID-19 on weight and well being

Antibiotic X-206 effective against SARS-CoV-2 in vitro

Hepatitis C virus co-opts an immune protein to evade antiviral defenses

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News